tm logo
INVASIGHT
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 29 Nov 2023

Last Applicant/ Owned by

Lengghalde 5

Zürich

CH

CH-8008

Serial Number

97516173 filed on 22nd Jul 2022

Registration Number

N/A

Correspondent Address

Nicholas D. Wells

LEGENDS LAW GROUP, PLLC

330 MAIN ST.

KAYSVILLE,UT 84037

Filing Basis

No Filing Basis

Disclaimer

NO DATA

INVASIGHT

Medical research; Pharmaceutical products development, particularly in the field of oncology; Scientific research in the field of chemistry, biochemistry and biology; Scientific research for medical purposes in the area of cancerous diseases; Research and development of vaccines and medicines, particularly anti-cancer invasion treatments; Hosting of a database; Hosting of a database for scientific Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical research; Pharmaceutical products development, particularly in the field of oncology; Scientific research in the field of chemistry, biochemistry and biology; Scientific research for medical purposes in the area of cancerous diseases; Research and development of vaccines and medicines, particularly anti-cancer invasion treatments; Hosting of a database; Hosting of a database for scientific research for medical purposes in the area of cancerous diseases; Hosting and development of data bases for research on anti-cancer treatments; Software as a Service (SaaS) featuring databank for oncology research; Design and development of computer hardware and software relating to research and development in the area of oncology; Hosting, Programming and Development of a drug discovery and development platform; Online data storage; Providing of access to a database for scientific and medical services; Consultancy and assistance in the medical sciences via an online platform; Hosting of an online platform for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research; Software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks, all of the given services particularly for oncology research

Class [009]
Computer & Software Products & Electrical & Scientific Products


Scientific apparatus and instruments for research in laboratories; Scientific apparatus and instruments for research in laboratories, particularly in the field of oncology and cancer treatment and prevention; Data processing equipment for research in the field of oncology; Electronic database for oncology research, particularly anti-cancer treatments; Software; Software for a database; Software for a database for oncology research

Class [005]
Pharmaceutical Products


Pharmaceuticals; Pharmaceutical preparations; Pharmaceutical and veterinary preparations and substances; preparations for healthcare; chemicals and chemical preparations and substances used for medical and pharmaceutical purposes and in medicines; dietetic substances for medical purposes; foods and beverages for babies, infants or invalids; vitamins; Anti-cancer drugs; Compounds for treating cancer, particularly anti-cancer invasion drugs; Diagnostic kits for research in the field of oncology, particularly cancer cell migration and invasion

Mark Details


Serial Number

No 97516173

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

Yes

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Nov 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
29th Nov 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
17th Aug 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
17th Aug 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
17th May 2023NON-FINAL ACTION WRITTEN
17th May 2023NON-FINAL ACTION E-MAILED
17th May 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
16th May 2023NON-FINAL ACTION WRITTEN
16th May 2023NON-FINAL ACTION E-MAILED
16th May 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED